Clinical trial
Trial of Decitabine as a Sensitizer to Carboplatin in Platinum Resistant…
NCT00477386 · Indiana University, Other · Completed
Key facts
| NCT number | NCT00477386 |
|---|---|
| Title | Trial of Decitabine as a Sensitizer to Carboplatin in Platinum Resistant Recurrent Ovarian Cancer |
| Official title | Phase I/II Trial of Decitabine as a Sensitizer to Carboplatin in Platinum Resistant Recurrent Ovarian Cancer |
| Lead sponsor | Indiana University, Other |
| Collaborators | Eisai Inc. Industry |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Ovarian Cancer |
| Intervention type | Drug |
| Interventions | decitabine |
| Enrollment | 28 |
| Start date | Jul 1, 2007 |
| Primary completion | May 1, 2011 |
| Completion | Sep 1, 2013 |
| First posted | May 23, 2007 |
| Last update posted | Sep 25, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: